4.5 Article

Interaction of lytic phage T1245 with antibiotics for enhancement of antibacterial and anti-biofilm efficacy against multidrug-resistant Acinetobacter baumannii

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Multidisciplinary Sciences

Enhanced antibacterial effect of a novel Friunavirus phage vWU2001 in combination with colistin against carbapenem-resistant Acinetobacter baumannii

Phitchayapak Wintachai et al.

Summary: The emergence of carbapenem-resistant Acinetobacter baumannii (CRAB) has posed greater challenges in treatment. This study isolated a novel phage vWU2001 with potential for combined therapy. Research conducted by East China University of Science and Technology.

SCIENTIFIC REPORTS (2022)

Article Chemistry, Medicinal

Isolation and Characterisation of Bacteriophage Selective for Key Acinetobacter baumannii Capsule Chemotypes

Rosesathorn Soontarach et al.

Summary: Nineteen bacteriophages against five main capsular types of multidrug-resistant Acinetobacter baumannii were isolated from hospital sewage. These phages demonstrated high burst size, short latent period, and quick adsorption to bacterial host. They also showed host specificity and stability over a wide range of temperatures and pH. Whole-genome analysis revealed high genomic similarity with double-stranded DNA and absence of toxin-coding genes. The study suggests that these phages have potential to be developed as antibacterial agents.

PHARMACEUTICALS (2022)

Article Infectious Diseases

Environmental Phage-Based Cocktail and Antibiotic Combination Effects onAcinetobacter baumanniiBiofilm in a Human Urine Model

Bartlomiej Grygorcewicz et al.

Summary: The combined treatment of phage cocktails with high lytic activity against MDR Acinetobacter baumanni infections and antibiotics has shown promising results in reducing bacterial biofilm biomass in human urine, demonstrating synergistic effects. This approach also resulted in a significantly greater reduction of biofilm biomass and clearance of persister cells.

MICROBIAL DRUG RESISTANCE (2021)

Article Infectious Diseases

Oxacillinase Gene Distribution, Antibiotic Resistance, and Their Correlation with Biofilm Formation inAcinetobacter baumanniiBloodstream Isolates

Ceren Ozkul et al.

Summary: The majority of A. baumannii bloodstream isolates in this study were characterized as blaOXA-51+OXA-23 carbapenemase genotype and strong biofilm formers. None of the isolates were positive for blaNDM-1, which was promising. Resistant isolates tended to form strong biofilms.

MICROBIAL DRUG RESISTANCE (2021)

Article Immunology

Genomic and phenotypic analyses of multidrug-resistant Acinetobacter baumannii NCCP 16007 isolated from a patient with a urinary tract infection

Misung Kim et al.

Summary: The multidrug-resistant Acinetobacter baumannii strain NCCP 16007 shows high resistance to Polymyxin B (PMB) and has acquired resistance through horizontal gene transfer of several antibiotic resistance genes. Despite losing some virulence factors, this strain exhibits high pathogenicity in infection models and has a high adhesion capacity during urinary tract infections.

VIRULENCE (2021)

Article Chemistry, Medicinal

Evaluation of the Synergistic Antibacterial Effects of Fosfomycin in Combination with Selected Antibiotics against Carbapenem-Resistant Acinetobacter baumannii

Ozioma F. Nwabor et al.

Summary: Combination therapy of fosfomycin with other antibiotics showed synergistic effects in inhibiting multi-drug resistant isolates, providing a potential alternative option for the treatment of MDR A. baumannii. Further studies are needed to assess its in vivo efficacy and toxicity in experimental models before clinical applications.

PHARMACEUTICALS (2021)

Article Microbiology

Identification of a Novel Ciprofloxacin Tolerance Gene, aciT, Which Contributes to Filamentation in Acinetobacter baumannii

Varsha Naidu et al.

Summary: The study identified a new gene, aciT, in Acinetobacter baumannii strain AB5075-UW that confers tolerance to ciprofloxacin by promoting filamentation. The disruption of aciT gene increased susceptibility to ciprofloxacin, while complementation restored tolerance levels. Orthologs of aciT are widely conserved in Acinetobacter species, indicating its importance in antibiotic response.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2021)

Article Immunology

A Potential Combination Therapy of Berberine Hydrochloride With Antibiotics Against Multidrug-Resistant Acinetobacter baumannii

Xiaobo Li et al.

Summary: Berberine hydrochloride (BBH) can enhance the susceptibility of multidrug-resistant Acinetobacter baumannii to antibiotics, even reversing their resistance, making it a potential promising therapeutic adjuvant against MDR strains.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2021)

Article Microbiology

Extensively Drug-Resistant Acinetobacter baumannii Nosocomial Pneumonia Successfully Treated with a Novel Antibiotic Combination

Noor Zaidan et al.

Summary: A successful case of treating XDR Acinetobacter baumannii pneumonia and septic shock with a novel antibiotic obtained via expanded access protocol was reported, suggesting that focused research and drug development efforts can mitigate the poor outcomes associated with these infections.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2021)

Article Immunology

Phenotypic and genotypic characteristics of Acinetobacter baumannii enrolled in the relationship among antibiotic resistance, biofilm formation and motility

Mona Mohamed Al-Shamiri et al.

Summary: Acinetobacter baumannii is a significant pathogen in clinical settings, exhibiting high levels of multidrug-resistance and biofilm formation ability. Research found a strong correlation between antibiotic resistance and biofilm formation, while no correlation was detected between twitching motility and antibiotic susceptibility or biofilm formation. The timing of examination was highlighted as a key factor in determining biofilm formation ability.

MICROBIAL PATHOGENESIS (2021)

Review Infectious Diseases

Antibiotic-Resistant Acinetobacter baumannii in Low-Income Countries (2000-2020): Twenty-One Years and Still below the Radar, Is It Not There or Can They Not Afford to Look for It?

Soha S. Rizk et al.

Summary: This study provides a comprehensive overview of the spread and drug resistance of A. baumannii in low-income countries, highlighting the lack of literature research, which may be mainly due to the lack of effective monitoring systems and financial resources.

ANTIBIOTICS-BASEL (2021)

Article Immunology

Colistin-phage combinations decrease antibiotic resistance in Acinetobacter baumannii via changes in envelope architecture

Xiaoqing Wang et al.

Summary: Multidrug-resistant bacterial infections are on the rise, leading to the search for new therapeutic approaches. Phage therapy is gaining attention as an alternative treatment strategy, but faces the challenge of phage-resistant bacteria. This study aims to understand the mechanisms of phage resistance in Acinetobacter baumannii and identifies potential strategies that could be exploited in clinical settings.

EMERGING MICROBES & INFECTIONS (2021)

Review Immunology

Insights Into Mechanisms of Biofilm Formation inAcinetobacter baumanniiand Implications for Uropathogenesis

Jennifer M. Colquhoun et al.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2020)

Article Biochemistry & Molecular Biology

Antibiotics Act with vB_AbaP_AGC01 Phage againstAcinetobacter baumanniiin Human Heat-Inactivated Plasma Blood andGalleria mellonellaModels

Bartlomiej Grygorcewicz et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Article Infectious Diseases

Biofilm-Induced Antibiotic Resistance in Clinical Acinetobacter baumannii Isolates

Abebe Mekuria Shenkutie et al.

ANTIBIOTICS-BASEL (2020)

Article Infectious Diseases

Eradication of persister cells of Acinetobacter baumannii through combination of colistin and amikacin antibiotics

Eun Seon Chung et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2019)

Article Biochemistry & Molecular Biology

Biofilm Formation in Acinetobacter Baumannii: Genotype-Phenotype Correlation

Cheng-Hong Yang et al.

MOLECULES (2019)

Review Infectious Diseases

Molecular mechanisms related to colistin resistance in Enterobacteriaceae

Zahra Aghapour et al.

INFECTION AND DRUG RESISTANCE (2019)

Article Microbiology

Dual Role of gnaA in Antibiotic Resistance and Virulence in Acinetobacter baumannii

Qingye Xu et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)

Review Pharmacology & Pharmacy

Ceftazidime stability and pyridine toxicity during continuous i.v. infusion

Terry E. Jones et al.

AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2019)

Review Microbiology

Uncovering the mechanisms of Acinetobacter baumannii virulence

Christian M. Harding et al.

NATURE REVIEWS MICROBIOLOGY (2018)

Article Biotechnology & Applied Microbiology

Phage-Antibiotic Synergy via Delayed Lysis

Minjin Kim et al.

APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2018)

Article Pharmacology & Pharmacy

Synergy of nebulized phage PEV20 and ciprofloxacin combination against Pseudomonas aeruginosa

Yu Lin et al.

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2018)

Article Microbiology

Role of Capsule in Resistance to Disinfectants, Host Antimicrobials, and Desiccation in Acinetobacter baumannii

Kyle A. Tipton et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)

Article Cell Biology

Phage Abp1 Rescues Human Cells and Mice from Infection by Pan-Drug Resistant Acinetobacter Baumannii

Supeng Yin et al.

CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)

Review Biotechnology & Applied Microbiology

Bacteriophage-encoded virion-associated enzymes to overcome the carbohydrate barriers during the infection process

Agnieszka Latka et al.

APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2017)

Article Immunology

Synergistic phage-antibiotic combinations for the control of Escherichia coli biofilms in vitro

Elizabeth M. Ryan et al.

FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY (2012)

Article Biotechnology & Applied Microbiology

Bacteriophage-Mediated Dispersal of Campylobacter jejuni Biofilms

Patcharin Siringan et al.

APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2011)